SEC Form 4 · accession 0001209191-17-047864
bluebird bio, Inc. · BLUE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Eric Sullivan
Officer — Principal Accounting Officer
Period of report
Aug 3, 2017
Accepted (ET)
Aug 7, 2017 · 4:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001293971
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 3, 2017 | M | 250 | $20.70 | A | 5,924 | D | |
| Common Stock | Aug 3, 2017 | M | 166 | $24.47 | A | 6,090 | D | |
| Common Stock | Aug 3, 2017 | S | 416 | $92.35 | D | 5,674 | D | |
| Common Stock | Aug 4, 2017 | M | 201 | $50.51 | A | 5,875 | D | |
| Common Stock | Aug 4, 2017 | M | 244 | $56.30 | A | 6,119 | D | |
| Common StockF1 | Aug 4, 2017 | S | 445 | $95.2128 | D | 5,674 | D | |
| Common StockF2 | holding | — | — | — | 300 | I | By spouse |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (right to buy)F3 | $20.70 | Aug 3, 2017 | M | 250 | D | — | Dec 2, 2023 | Common Stock | 250 | 750 | D |
| Stock Option (right to buy)F4 | $24.47 | Aug 3, 2017 | M | 166 | D | — | Mar 3, 2024 | Common Stock | 166 | 854 | D |
| Stock Option (right to buy)F5 | $50.51 | Aug 4, 2017 | M | 201 | D | — | Mar 1, 2026 | Common Stock | 201 | 5,868 | D |
| Stock Option (right to buy)F6 | $56.30 | Aug 4, 2017 | M | 244 | D | — | Aug 1, 2026 | Common Stock | 244 | 8,558 | D |
Explanation of responses
- F1The range in prices for the transaction reported on this line was $95.10 to $95.30. The average weighted price was $95.2128. The reporting person will provide, upon request by the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
- F2Equity grants held by the reporting person's spouse, who is employed by the issuer
- F3This option vests over a four-year period, at a rate of twenty-five percent (25%) on November 11, 2014 and in 36 equal monthly installments thereafter.
- F4This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 1, 2015 and in 36 equal monthly installments thereafter.
- F5This option vests over a four-year period, at a rate of twenty-five percent (25%) on January 4, 2017, and in 36 equal monthly installments.
- F6This option vests over a four-year period, at a rate of twenty-five percent (25%) on July 4, 2017 and in 36 equal monthly installments thereafter.